Impact of Renin-Angiotensin-Aldosterone-System Inhibition on Advanced Chronic Kidney Disease progression – a Retrospective Observational Study
Recruiting
- Conditions
- N18.4Chronic kidney disease, stage 4
- Registration Number
- DRKS00034706
- Lead Sponsor
- niversitätsklinikum Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 6000
Inclusion Criteria
Patients treated at the University of Freiburg Medical Center
- Treated between 01/01/2001 – 12/31/2024
- = 2 serum-creatinine values
- eGFR <60 ml/miin/1.73m2
Exclusion Criteria
- hemo- or peritoneal dialysis
- kidney transplantation
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Annual decline in eGFR until primary endpoint (end-stage renal disease (eGFR <15 ml/min/1.73m2) is reached in patients with eGFR of 15 - 30 ml/min/1.73 m2 at baseline
- Secondary Outcome Measures
Name Time Method Annual decline in eGFR until secondary endpoint (eGFR <30 ml/min/1.73m2) is reached in patients with eGFR of 31 -601ml/min/1.73 m2 at baseline